2010 Fiscal Year Final Research Report
Developing new treatment modalities of bladder cancer on the basis of microRNA expression profile
Project/Area Number |
20591861
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Urology
|
Research Institution | Kagoshima University |
Principal Investigator |
KAWAMOTO Ken Kagoshima University, 医歯学総合研究科, 研究員 (80363620)
|
Co-Investigator(Kenkyū-buntansha) |
ENOKIDA Hideki 鹿児島大学, 医歯学総合研究科, 講師 (80347103)
|
Research Collaborator |
千代丸 剛 鹿児島大学, 医歯学総合研究科, 大学院生
鑪野 秀一 鹿児島大学, 医歯学総合研究科, 大学院生
吉野 裕史 鹿児島大学, 医歯学総合研究科, 大学院生
|
Project Period (FY) |
2008 – 2010
|
Keywords | マイクロRNA / 膀胱癌 / 腫瘍マーカー |
Research Abstract |
We screened 157 microRNAs and identified the microRNA profile in clinical bladder cancer. We focused on the down-regulated microRNAs, such as miR-133a, and miR-145, which may have tumor suppressive function. Transfection of the target genes, such as KRT-7, FSCN1, and GST-P1, revealed that these genes might have oncogenic function. On the other hand, the expression levels of the up-regulated microRNAs, such as miR-96, miR-183, were indeed over-expressed in bladder cancer, suggesting that they might be potential biomarkers for bladder cancer.
|
-
-
[Journal Article] miR-218 on the genomic loss region of chromosome 4p15.31 functions as a tumor suppressor in bladder cancer.2011
Author(s)
Tatarano S, Chiyomaru T, Kawakami K, Enokida H, Yoshino H, Hidaka H, Yamasaki T, Kawahara K, Nishiyama K, Seki N, Nakagawa M.
-
Journal Title
Int J Oncol. 39
Pages: 13-21
Peer Reviewed
-
[Journal Article] Restoration of miR-517a expression induces cell apoptosis in bladder cancer cell lines.2011
Author(s)
Yoshitomi T, Kawakami K, Enokida H, Chiyomaru T, Kagara I, Tatarano S, Yoshino H, Arimura H, Nishiyama K, Seki N, Nakagawa M.
-
Journal Title
Oncol Rep. 25
Pages: 1661-1668
Peer Reviewed
-
-
[Journal Article] MiR-96 and miR-183 detection in urine serve as potential tumor markers of urothelial carcinoma : correlation with stage and grade, and comparison with urinary cytology.2011
Author(s)
Yamada Y, Enokida H, Kojima S, Kawakami K, Chiyomaru T, Tatarano S, Yoshino H, Kawahara K, Nishiyama K, Seki N, Nakagawa M.
-
Journal Title
Cancer Sci. 102
Pages: 522-529
Peer Reviewed
-
[Journal Article] LY6K is a novel molecular target in bladder cancer on basis of integrate genome-wide profiling.2011
Author(s)
Matsuda R, Enokida H, Chiyomaru T, Kikkawa N, Sugimoto T, Kawakami K, Tatarano S, Yoshino H, Toki K, Uchida Y, Kawahara K, Nishiyama K, Seki N, Nakagawa M.
-
Journal Title
Br J Cancer. 104
Pages: 376-386
Peer Reviewed
-
-
[Journal Article] Identification of novel microRNA targets based on microRNA signatures in bladder cancer.2009
Author(s)
Ichimi T, Enokida H, Okuno Y, Kunimoto R, Chiyomaru T, Kawamoto K, Kawahara K, Toki K, Kawakami K, Nishiyama K, Tsujimoto G, Nakagawa M, Seki N.
-
Journal Title
Int J Cancer. 125
Pages: 345-52
Peer Reviewed
-
-
-
-
-
-
-
-
-
-